Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00007319 · ClinicalTrials.gov registry record
Carotid Artery Thickness in HIV Infected and Uninfected Adults
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 132
- Enrollment target
NCT00007319: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00007319 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 132 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00007319 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
Study Summary
The intima-media thickness (IMT) test is a low cost, non-invasive way to measure the thickness of the carotid artery (the large artery in the neck). The purpose of this study is to compare the thickness of the carotid artery among HIV infected adults taking protease inhibitors (PIs), HIV infected adults not taking PIs, and HIV uninfected adults, and to examine how the thickness may change over time.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
What the finished NCT00007319 record still lists
NCT00007319 is an observational study that tracks outcomes without assigning an intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00007319 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00007319 about?
NCT00007319 is a clinical study titled "Carotid Artery Thickness in HIV Infected and Uninfected Adults". The intima-media thickness (IMT) test is a low cost, non-invasive way to measure the thickness of the carotid artery (the large artery in the neck). The purpose of this study is to compare the thickness of the carotid artery among HIV infected adults taking protease inhibitors (PIs), HIV infected ad...
What is the current status of trial NCT00007319?
This trial is currently completed. The enrollment target is 132 participants.
Who is sponsoring clinical trial NCT00007319?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain